At LightRx, we use Semaglutide, a GLP-1 medication designed to reduce hunger, jumpstart fat loss, and boost feelings of fullness for long-term success
We secure manufacturer discounts to keep monthly costs predictable
Resting Energy Expenditure Small-scale indirect calorimetry studies suggest tirzepatide modestly increases resting energy expenditure (REE) beyond what weight loss alone predicts, an effect not consistently seen with liraglutide or semaglutide at approved doses
Both doses led to an increase in maximal respiration and ATP-linked respiration in HC cells, while mitochondrial biogenesis and oxidative phosphorylation gene expression remained unchanged, suggesting that UA specifically enhances mitochondrial respiration to improve chondrocyte metabolic function
But no drug is without its risks, and we should definitely be keeping a close eye on how these groups will fare on GLP-1s over the long term